nach oben

PharmacoEconomics

Erschienen in:

01.08.2006 | Correspondence

National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget

verfasst von: Slobodan M. Jankovic, Nebojsa Milivojevic

Erschienen in: PharmacoEconomics | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Seoane Vázquez EC, Rodríguez-Monguió R. Analisis del Impacta de la Negociacion de Precios de Medicamentos y Reactivos para el VIHlSIDA en los Paises Andinos. Report for Organizacion Pan Americana de la Salud [online]. Available from URL: http://www.paho.org/Spanish/AD/FCH/AI/NegociacionPreciosVIH.pdf [Accessed 2006 Jul 3]

Decision on standards for administration of cytostatics which are not on the list of drugs. Belgrade: Managing Board of Republic Institute for Health Insurance, 2004 Apr. Report no.: 54-333/04

Decision on list of drugs which are prescribed and dispensed on account of health insurance. Official Gazette of Republic of Serbia 2005; 61 (6): 1-111

Instructions for prescribing and dispensing drugs with special dispensing regime. Belgrade: Republic Institute for Health Insurance, 2005

Decision on standards for administration of cytostatics and other specific drugs for treatment of malignant diseases, which are on the list of drugs. Belgrade: Managing Board of Republic Institute for Health Insurance, 2005. Nurmer 54-279/05

Stokoe H, Samways D. Purchasing medicines. In: Stephens M, editor. Hospital pharmacy. 1st ed. London: Pharmaceutical Press, 2003: 17–28

Titel: National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
verfasst von: Slobodan M. Jankovic
Nebojsa Milivojevic
Publikationsdatum: 01.08.2006
Verlag: Springer International Publishing
Erschienen in: PharmacoEconomics / Ausgabe 8/2006
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI: https://doi.org/10.2165/00019053-200624080-00008

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2006

Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension

Costs of Inflammatory Bowel Disease in Germany

Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease

A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials

Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada

A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction